As of 14 Oct 2026, Pelage has raised $120M across 1 verified round on record; latest: $120 million Series B led by Arch Venture Partners and GV (Google Ventures), announced 15 Oct 2025.
Pelagepharma develops regenerative medicines focused on treating hair loss using stem cell technology.
2 sources
Sources agree. The Los Angeles dateline is not treated as the company's headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2025-10-15 | Arch Venture Partners, GV (Google Ventures) | No recent discussion |
2 sources [ VERIFIED · CORRECTED ] read against 2 sources Sources agree. The Los Angeles dateline is not treated as the company's headquarters. | ||||